Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Tax Rate (2018 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Tax Rate for 5 consecutive years, with 0.74% as the latest value for Q4 2025.

  • Quarterly Tax Rate fell 75.0% to 0.74% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 170.17% through Dec 2025, up 16867.0% year-over-year, with the annual reading at 176.05% for FY2025, 17454.0% up from the prior year.
  • Tax Rate hit 0.74% in Q4 2025 for Protagonist Therapeutics, up from 0.5% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 2.24% in Q2 2024 to a low of 0.5% in Q2 2025.